Biotech MacroGenics Inc. is growing its footprint, recently leasing 122,000 square feet of wet lab space in the J. Craig Venter Institute in Rockville.
The clinical-stage biopharmaceutical company, which focuses on antibody-based therapies for cancer treatment and other diseases, will use the space for its commercial manufacturing of early clinical stage molecules, CEO Scott Koenig said.